LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced a delay in the dispatch of its circular related to the Entrusted Products Related Framework Agreement, extending the date to on or before November 20, 2024. This postponement allows more time to prepare and finalize vital information for shareholders. Investors in LEPU ScienTech should stay informed about these developments that may impact their investment decisions.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.